Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients
Crossref DOI link: https://doi.org/10.1007/s10238-015-0370-5
Published Online: 2015-06-19
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Negrini, Simone
Spanò, Francesca
Penza, Elena
Rollando, Daniela
Indiveri, Francesco
Filaci, Gilberto
Puppo, Francesco
Text and Data Mining valid from 2015-06-19